Gene Therapy Finds a Fertile Home in Ohio
January 13, 2020
The midwestern state has quietly laid the groundwork for a biotech hub.
Sarepta Therapeutics’s outpost in Ohio occupies a collection of offices and labs on the second floor of a large, squat structure known as “Building 4” in a business park outside of Columbus. Despite the facility’s unassuming exterior, the start of research onsite here in spring 2019 marked a milestone in Ohio’s two-decade-long march toward becoming a gene therapy hub. “We’re making a very significant commitment and investment in Columbus,” Doug Ingram, the CEO of Cambridge, Massachusetts–based Sarepta, told Columbus Business First in an article about the new division. “There is a real chance Columbus, Ohio, could become the most important place in the world for gene therapy development.”
